Ruling Could Cut Off 40 Million Women’s Abortion Access, NARAL Study Says

Anti-abortion advocates are trying to revoke the FDA’s approval of the abortion pill mifepristone, and a ruling could come within weeks.

Read the full post on Forbes - Healthcare